April 7, 2022
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
Meeting Scheduled for April 8, 2022 at 9:00 AM ET NEW YORK, NY, April 06, 2022 (GLOBE NEWSWIRE) — Enzo…
Pharmaceuticals, Biotechnology and Life Sciences
Meeting Scheduled for April 8, 2022 at 9:00 AM ET NEW YORK, NY, April 06, 2022 (GLOBE NEWSWIRE) — Enzo…
OSLO, Norway and DALLAS, April 06, 2022 (GLOBE NEWSWIRE) — The Coalition for Epidemic Preparedness Innovations (CEPI) and Vaxxinity, Inc.…
MOUNTAIN VIEW, Calif., April 06, 2022 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (NASDAQ: IGMS) today announced the closing on April…
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell…
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present…
Revenue Sharing Arrangement with University of Oxford Could Deliver Further Payments to Vaccitech Arising from Milestones and RoyaltiesOXFORD, United Kingdom,…
ZUG, Switzerland, April 06, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to…
SAN DIEGO and GAINESVILLE, Ga., April 06, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract…
ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology…
CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and…